MedPath

Capasal Therapeutic Shampoo

Marketing Authorization Holder: Diomed Developments Limited T/A Dermal Laboratories Tatmore Place, Gosmore Hitchin, Herts, SG4 7QR, UK

Authorised
Legal Category

Pharmacy

ATC Code

D05AA

Authorization Number

PL 00173/0048

Summary of Product Characteristics

Detailed prescribing information and pharmaceutical guidance from the UK Electronic Medicines Compendium.

Composition

Active and inactive ingredients

| | | | --- | --- | | Distilled coal tar | 1.0% w/w | | Salicylic acid | 0.5% w/w | | Coconut oil | 1.0% w/w | Excipients with known effect: Sodium benzoate (E 211) For the full list of excipients, see section 6.1.

Pharmaceutical Form

Dosage form and administration route

Shampoo Viscous, golden brown shampoo

Clinical Particulars

Therapeutic indications and usage

4.1 Therapeutic indications For use as a shampoo in the treatment of dry, scaly scalp conditions such as seborrhoeic eczema, seborrhoeic dermatitis, pityriasis capitis, psoriasis and cradle cap in children. It may also be used to remove previous scalp applications.4.2 Posology and method of administration For adults, children and the elderly. Use as a shampoo, daily if necessary, reducing the frequency of use to once or twice a week as the condition improves. Thereafter, occasional use may be necessary. Wet the hair thoroughly. Massage a small amount of the shampoo into the scalp (approximately a quantity the size of a fifty pence piece for short hair, adjusting up depending on length/thickness of hair), leaving on for a few minutes before washing out. If necessary, repeat, producing a rich lather. Rinse hair well and dry.4.3 Contraindications Not to be used in cases of hypersensitivity to the active substances or to any of the excipients listed in section 6.1.4.4 Special warnings and precautions for use Keep away from the eyes. Keep out of the sight and reach of children. For external use only. This medicine contains 0.15mg of sodium benzoate (E 211) per gram of shampoo. Sodium benzoate (E 211) may cause local irritation. Sodium benzoate may increase jaundice (yellowing of the skin and eyes) in newborn babies (up to 4 weeks old). In case of irritation, or if there is no improvement after 4 weeks, or the scalp condition seems to look or feel worse, discontinue treatment and tell your doctor, pharmacist or nurse.4.5 Interaction with other medicinal products and other forms of interaction None known.4.6 Fertility, pregnancy and lactation No known side effects.4.7 Effects on ability to drive and use machines None known.4.8 Undesirable effects None known. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.4.9 Overdose There are no known toxic effects resulting from excessive use of Capasal.

Pharmacological Properties

Pharmacodynamics and pharmacokinetics

5.1 Pharmacodynamic properties Pharmacotherapeutic group: Antipsoriatics for topical use, Tars. ATC code: D05AA. The preparation has been designed as an aid in the treatment of dry, scaly scalp conditions by incorporating into a shampoo formulation three well known ingredients which have been established as safe and effective for use in this indication. They are as follows: | | | | | --- | --- | --- | | 1.0% distilled coal tar | - | anti-pruritic, keratoplastic | | 0.5% salicylic acid | - | mild keratolytic | | 1.0% coconut oil | - | emollient, softening agent and lubricant | The preparation may also be used conveniently to remove any previous topical application.5.2 Pharmacokinetic properties The active ingredients of the formulation are readily available for intimate contact with the skin, as the shampoo is massaged into the scalp and left on for a few minutes before washing out. This is then repeated in order to produce a rich lather. The detergent effect of the shampoo will also remove any previous application to the scalp.5.3 Preclinical safety data There are no preclinical data of relevance to the prescriber, which are additional to those already included in other sections of the SmPC.

Pharmaceutical Particulars

Storage and handling information

6.1 List of excipients Lauric acid diethanolamide Coco amido propyl dimethyl betaine (contains sodium benzoate as a preservative) Triethanolamine lauryl sulfate (trolamine lauril sulfate) (contains methylchloroisothiazolinone /methylisothiazolinone (3:1) as a preservative) Phenoxyethanol Ammonium sulfate Water, purified6.2 Incompatibilities Not applicable.6.3 Shelf life 36 months in unopened container.6.4 Special precautions for storage Do not store above 25°C. Keep away from direct sunlight.6.5 Nature and contents of container 30 ml high density polyethylene bottles with polypropylene screwcaps. 50, 100, 125, 150, 200, 250, 300, 350 and 500 ml high density polyethylene bottles with polypropylene dispensing screwcaps. 10 ml aluminium foil/polyester/polyethylene laminate sachets. Not all pack sizes may be marketed.6.6 Special precautions for disposal and other handling Not applicable.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.